Contrary (San Francisco)

Venture capital · San Francisco, California

Contrary (San Francisco) is a venture capital firm based in San Francisco, California. Founded in 2017, Contrary is a venture capital firm based in San Francisco, California. 32 portfolio companies and 7 recorded rounds are on record.

AUM
$287.8M
Portfolio companies
32
Recorded deals
7
10 in last 12M
Last investment
Mar 2026

Contrary (San Francisco) key facts

  • Contrary (San Francisco) is a venture capital firm based in San Francisco, California with 32 tracked portfolio companies.
  • Notable positions include Anduril Industries, Ramp, Replit.
  • PrivateMarketView records 7 deal participations by Contrary (San Francisco).
  • Contrary (San Francisco)’s most recent recorded investment was in Mar 2026, one of 10 in the last 12 months and 18 over two years.
  • The team roster lists 3 people.

About Contrary (San Francisco)

Founded in 2017, Contrary is a venture capital firm based in San Francisco, California. This firm is a Registered Investment Adviser (RIA). The firm prefers to invest in the technology and healthcare sectors.

Investment activity

Contrary (San Francisco) joined 1 recorded round in the last two years, down from 3 in the two years before. By year: 1 in 2026, 1 in 2024 and 2 in 2023. Across all 7 recorded rounds, 4 were later-stage and 3 were early-stage. Contrary (San Francisco) most often invests alongside 8VC (4 shared rounds), D1 Capital Partners (4 shared rounds) and Founders Fund (4 shared rounds). Most recently: Valar Atomics (early-stage round, Mar 2026) and Ramp (Series D2, Apr 2024).

Contrary (San Francisco) portfolio at a glance

32 portfolio companies are on record for Contrary (San Francisco), including Anduril Industries, Ramp and Replit.

19 of the 32 carry a recorded valuation and 5 have recorded secondary-market trades, the names a secondary buyer or seller can price.

Contrary (San Francisco) team

3 people are on record at Contrary (San Francisco): 2 partners and 1 managing partner. Senior names include Eric Tarczynski (Founder), Jason Chen (Partner) and Megan Kao (Principal). 3 of them have a verified direct contact on file.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Contrary (San Francisco) at the SEC

Form ADV · 2026-03 · CRD 311054
Regulatory AUM
—
Private fund assets
$480.5M
Private funds
11 · 11 venture
Staff
12
Registered office
—
SEC status
Approved

Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as CONTRARY LLC).

Free account
See more of the book
  • ·The top 10 names in the book — of 32 recorded positions
  • ·The 10 latest deals — of 7 rounds
  • ·Watchlist + alerts for Contrary (San Francisco)'s activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

32 companies · priced for members
CompanyValuationRole
Anduril Industries▮▮
Ramp▮▮
Replit▮▮
+ 29 more companies · all 32, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Contrary (San Francisco) recent deals

7 recorded
Mar 2026Valar AtomicsEarly Stage VC▮
Apr 2024RampSeries D2▮
Dec 2023Armada (Commercial Products)Early Stage VC (Series A)▮
+ 4 more deals · amounts and lead flags are a member featureUnlock all 7 deals

Membership and data by Private Market View

Team
3 people on record — 3 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked about Contrary (San Francisco)

What companies does Contrary (San Francisco) invest in?
Contrary (San Francisco) has 32 recorded portfolio companies, including Anduril Industries, Ramp, Replit.
What is Contrary (San Francisco)'s AUM?
Contrary (San Francisco) manages approximately $287.8M in assets.
Is Contrary (San Francisco) actively investing?
Contrary (San Francisco)'s most recent recorded investment was in Mar 2026, with 10 investments in the last 12 months.